cancer clinical trials for Breast (ONC)
14 Breast (ONC) clinical trials found. View a list of all cancer clinical trial types.
-
Phase II trial to evaluate immune-related biomarkers for pathological response in stage II-III HER2-positive breast cancer receiving neoadjuvant chemotherapy with subsequent randomization to multi-epitope HER2 vaccine vs. placebo in patients with residual disease post-neoadjuvant chemotherapy
Current Status: Open
View links and contact information related to this clinical trial -
A Phase III Clinical Trial Evaluating De-Escalation of Breast Radiation for Conservative Treatment of Stage I, Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer
Current Status: Open
View links and contact information related to this clinical trial -
OptimICE-PCR: De-Escalation of Therapy in Early-Stage TNBC Patients Who Achieve pCR After Neoadjuvant Chemotherapy with Checkpoint Inhibitor Therapy
Current Status: Open
View links and contact information related to this clinical trial -
Integrating eHealth and Lay Navigation to Optimize Treatment Initiation and Adherence (REALIZ) among Black Women with Breast Cancer: A Pilot Implementation Feasibility Study
Current Status: Open
View links and contact information related to this clinical trial -
A phase II clinical trial assessing the safety of neoadjuvant palbociclib in combination with endocrine therapy for post and pre-menopausal patients with early stage hormone receptor positive and Her-2/neu negative breast cancer
Current Status: Open
View links and contact information related to this clinical trial -
Evaluation of Gut Microbiome Diversity in Breast Cancer Survivors Following Active Cancer Therapy
Current Status: Open
View links and contact information related to this clinical trial -
A Randomized, Multicenter, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects With Residual Disease or High-Risk PCR After Both Neoadjuvant and Postoperative Adjuvant Trastuzumab-based Therapy (FLAMINGO-01)
Current Status: Open
View links and contact information related to this clinical trial -
ESTABLISHMENT OF A NATIONAL BIOREPOSITORY TO ADVANCE STUDIES OF IMMUNE-RELATED ADVERSE EVENTS
Current Status: Open
View links and contact information related to this clinical trial -
Interim FDG-PET/CT for PreDIcting REsponse of HER2+ Breast Cancer to Neoadjuvant Therapy: DIRECT Trial
Current Status: Open
View links and contact information related to this clinical trial -
Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain
Current Status: Open
View links and contact information related to this clinical trial -
A Randomized Study Evaluating GLIADEL Compared to Stereotactic Radiosurgery in Patients with Metastatic Brain Disease
Current Status: Open
View links and contact information related to this clinical trial -
Testing Radiation and HER2-targeted Therapy Versus HER2-targeted Therapy Alone for Low-risk HER2-positive Breast Cancer (HERO)
Current Status: Open
View links and contact information related to this clinical trial -
Shorter Anthracycline-Free Chemo Immunotherapy Adapted to Pathological Response in Early Triple Negative Breast Cancer (SCARLET), A Randomized Phase III Study
Current Status: Open
View links and contact information related to this clinical trial -
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25 (OFSET)
Current Status: Open
View links and contact information related to this clinical trial